MDG — Medicalgorithmics SA Cashflow Statement
0.000.00%
- PLN252.80m
- PLN250.40m
- PLN43.10m
Annual cashflow statement for Medicalgorithmics SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.299 | -27.7 | -181 | -30.4 | -0.578 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.619 | 0.177 | 151 | 5.16 | 1.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.54 | 7.65 | 5.91 | 27.4 | -3.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 13.5 | -3.96 | -6.48 | 6.33 | 0.182 |
Capital Expenditures | -3.82 | -0.415 | -9.91 | — | -0.488 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1.03 | -4.59 | -5.87 | -1.81 | 2.45 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -2.79 | -5 | -15.8 | -1.81 | 1.96 |
Financing Cash Flow Items | -58.7 | 16.8 | 15.1 | -0.763 | 1.61 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -59.7 | 14 | 17.7 | 9.98 | -2.81 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -49 | 5.05 | -4.53 | 14.5 | -0.664 |